TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | 12 | 32 | 4 | 14 | 0 | 13 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/25 16:17 | 2/4/25 | MBX | Mbx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | IN | DO | P,CEO | P.d | 535 | 10.69 | 0 | 50 | 6 | 930 | I | ||||||||||||||
3/14/17 17:46 | 3/10/17 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | MI | D | P.d | 237 | 9.47 | 0 | 25 | 28 | 114 | I | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | ||||||
8/12/16 13:27 | 8/10/16 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | MI | D | P.d | 250 | 10.00 | 0 | 25 | 39 | 89 | I | 0 | 7 | 13 | 39 | 4 | 14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |